{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:57:01Z","timestamp":1784325421960,"version":"3.55.0"},"reference-count":43,"publisher":"Cambridge University Press (CUP)","issue":"8","license":[{"start":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T00:00:00Z","timestamp":1490140800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The primary study objective was to investigate three decades from 1985 to 2014 of changes in pregnancies among HIV-infected women. The secondary objective was to assess risk factors associated with preterm delivery and severe small-for-gestational-age (SGA) infants in HIV-infected women. A retrospective review of deliveries among pregnant HIV-infected women at the University of Genoa and IRCCS San Martino-IST in Genoa between 1985 and 2014 was performed. Univariate and multivariable analyses were used to study the variables associated with neonatal outcomes. Overall, 262 deliveries were included in the study. An increase in median age (26 years in 1985\u20131994 <jats:italic>vs<\/jats:italic>. 34 years in 2005\u20132014), in the proportion of foreigners (none in 1985\u20131994 <jats:italic>vs.<\/jats:italic> 27\/70 (38\u00b76%) in 2005\u20132014), and a decrease in intravenous drug use (75\u00b72% (91\/121) in 1985\u20131994 <jats:italic>vs.<\/jats:italic> 12\u00b79% (9\/70) in 2005\u20132014) among pregnant HIV-infected women was observed. Progressively, HIV infections were diagnosed sooner (prior to pregnancy in 80% (56\/70) of women in the last decade). An increase in combined antiretroviral therapy (cART) prescription during pregnancy (50% (27\/54) in 1995\u20132004 <jats:italic>vs.<\/jats:italic> 92\u00b72% (59\/64) in 2005\u20132014) and in HIV-RNA &lt;50 copies\/ml at delivery (19\u00b72% (5\/26) in 1995\u20132004 <jats:italic>vs.<\/jats:italic> 82\u00b73% (53\/64) in 2005\u20132014) was observed. The rate of elective caesarean section from 1985 to 1994 was 9\u00b71%, which increased to 92\u00b73% from 2004 to 2015. Twelve (10\u00b71%) mother-to-child transmissions (MTCT) occurred in the first decade, and six (8\u00b73%) cases occurred in the second decade, the last of which was in 2000. Preterm delivery (&lt;37 weeks gestation) was 5% (6\/121) from 1985 to 1994 and increased to 17\u00b71% (12\/70) from 2005 to 2014. In univariate and multivariable logistic regression analyses, advancing maternal age and previous pregnancies were associated with preterm delivery (odds ratio (OR) 2\u00b77; 95% confidence intervals (CI) 1\u20137\u00b78 and OR 2\u00b76; 95% CI 1\u00b71\u20136\u00b77, respectively). In the logistic regression analysis, use of heroin or methadone was found to be the only risk factor for severe SGA (OR 3\u00b71; 95% CI 1\u00b74\u20136\u00b78). In conclusion, significant changes in demographic, clinical and therapeutic characteristics of HIV-infected pregnant women have occurred over the last 30 years. Since 2000, MTCT has decreased to zero. An increased risk of preterm delivery was found to be associated with advancing maternal age and previous pregnancies but not with cART. The use of heroin or methadone has been confirmed as a risk factor associated with severe SGA.<\/jats:p>","DOI":"10.1017\/s095026881700053x","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T07:36:38Z","timestamp":1490168198000},"page":"1658-1669","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":8,"title":["Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study"],"prefix":"10.1017","volume":"145","author":[{"given":"S.","family":"GRIGNOLO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"AGNELLO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"GERBALDO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"GOTTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"ALICINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"DEL PUENTE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"TARAMASSO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"BRUZZONE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"GUSTAVINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"TRASINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"DE MARIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"ICARDI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"VISCOLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"DI BIAGIO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2017,3,22]]},"reference":[{"key":"S095026881700053X_ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7219.1227"},{"key":"S095026881700053X_ref11","unstructured":"Societ\u00e0 Italiana di Malattie Infettive e Tropicali (SIMIT). Linee Guida Italiane sull'utilizzo dei farmaci antiretrovirali e sulla gestione diagnostico-clinica delle persone con infezione da HIV-1, 2016 (http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2545_allegato.pdf). Accessed 3 January 2017."},{"key":"S095026881700053X_ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904013401301"},{"key":"S095026881700053X_ref13","article-title":"Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study","volume":"208","author":"Unterscheider","year":"2013","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"S095026881700053X_ref32","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32802ef2f6"},{"key":"S095026881700053X_ref29","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199818000-00002"},{"key":"S095026881700053X_ref21","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283565df1"},{"key":"S095026881700053X_ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199705010-00012"},{"key":"S095026881700053X_ref30","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328133884b"},{"key":"S095026881700053X_ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-486X.2007.00243.x"},{"key":"S095026881700053X_ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411033311801"},{"key":"S095026881700053X_ref9","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200104130-00012"},{"key":"S095026881700053X_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2014.02.005"},{"key":"S095026881700053X_ref10","unstructured":"EACS. European AIDS Clinical Society Guidelines Version 8.0 October 2015. (http:\/\/www.eacsociety.org\/files\/2015_eacsguidelines_8_0-english_rev-20160124.pdf). Accessed 18 March 2016."},{"key":"S095026881700053X_ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1511691"},{"key":"S095026881700053X_ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.01.025"},{"key":"S095026881700053X_ref16","doi-asserted-by":"publisher","DOI":"10.1214\/09-SS051"},{"key":"S095026881700053X_ref31","doi-asserted-by":"publisher","DOI":"10.1086\/503045"},{"key":"S095026881700053X_ref17","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000183"},{"key":"#cr-split#-S095026881700053X_ref8.1","unstructured":"3. EUROSTAT news release 15 May 2015"},{"key":"#cr-split#-S095026881700053X_ref8.2","unstructured":"4. International day of families. Women in EU gave birth to their first child at almost 29 years of age on average. (http:\/\/ec.europa.eu\/eurostat\/documents\/2995521\/6829228\/3-13052015-CP-EN.pdf\/7e9007fb-3ca9-445f-96eb-fd75d6792965). Accessed 07 November 2016."},{"key":"S095026881700053X_ref15","doi-asserted-by":"publisher","DOI":"10.1002\/0470114754"},{"key":"S095026881700053X_ref23","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckt028"},{"key":"S095026881700053X_ref22","unstructured":"Report ISTAT. Gravidanza, parto e allattamento al seno. Istituto Nazionale di Statistica (ISTAT) 2013. (http:\/\/www.istat.it\/it\/files\/2014\/12\/gravidanza.pdf?title=Gravidanza%2C+parto+e+allattamento+al+seno+-+09%2Fdic%2F2014+-+Testo+integrale.pdf). Accessed 18 March 2016."},{"key":"S095026881700053X_ref20","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182a334e3"},{"key":"S095026881700053X_ref19","doi-asserted-by":"publisher","DOI":"10.1310\/hct1403-110"},{"key":"S095026881700053X_ref27","doi-asserted-by":"publisher","DOI":"10.1086\/427287"},{"key":"S095026881700053X_ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa991159"},{"key":"S095026881700053X_ref6","first-page":"100","article-title":"Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of < or = 500\/microL","volume":"183","author":"Watts","year":"2000","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"S095026881700053X_ref5","unstructured":"Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. (http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/PerinatalGL.pdf). Accessed 28 March 2016."},{"key":"S095026881700053X_ref3","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000212"},{"key":"S095026881700053X_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2015.06.021"},{"key":"S095026881700053X_ref1","unstructured":"World Health Organization. Programmatic update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. (http:\/\/www.who.int\/hiv\/PMTCT_update.pdf). Accessed 13 May 2016."},{"key":"S095026881700053X_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2010.01.014"},{"key":"S095026881700053X_ref24","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199802000-00011"},{"key":"#cr-split#-S095026881700053X_ref2.1","unstructured":"8. Centers for Disease Control and Prevention. Enhanced perinatal surveillance-15 areas, 2005-2008. HIV Surveillance Supplemental Report 2011"},{"key":"#cr-split#-S095026881700053X_ref2.2","unstructured":"9. 16(2). (http:\/\/www.cdc.gov\/hiv\/pdf\/statistics_2005_2008_HIV_Surveillance_Report_vol_16_no2.pdf). Accessed 11 November 2016."},{"key":"S095026881700053X_ref40","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu190"},{"key":"S095026881700053X_ref34","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200304010-00006"},{"key":"#cr-split#-S095026881700053X_ref4.1","unstructured":"10. Istituto Superiore di Sanit??. Dati HIV AIDS - Notiziario Istituto Superiore di Sanit?? (ISS) 2015"},{"key":"#cr-split#-S095026881700053X_ref4.2","unstructured":"11. 28(9), Supplement 1. (http:\/\/www.iss.it\/binary\/ccoa\/cont\/HIV_AIDS_DIC_2015.pdf). Accessed 18 March 2016."},{"key":"S095026881700053X_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.10.862"},{"key":"S095026881700053X_ref18","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f9b67a"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S095026881700053X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T22:41:32Z","timestamp":1555540892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S095026881700053X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,22]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S095026881700053X"],"URL":"https:\/\/doi.org\/10.1017\/s095026881700053x","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,22]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2017\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}